Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02807558
Title A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Syros Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Hartford Connecticut United States Details
Miami Florida United States Details
Iowa City Iowa United States Details
Boston Massachusetts United States Details
Ann Arbor Michigan United States Details
New York New York United States Details
Rochester New York United States Details
Durham North Carolina United States Details
Cleveland Ohio United States Details
Portland Oregon United States Details
Allentown Pennsylvania United States Details
Pittsburgh Pennsylvania United States Details
Nashville Tennessee United States Details
Houston Texas United States Details
CHU Amiens Amiens France Details
Centre Hospitalier de la Côte basque Bayonne France Details
Centre Hospitalier Universitiaire Hopital Avicenne Bobigny France Details
Hospital Morvan Brest France Details
Centre Hospitalier de Versailles - Hôpital André Mignot Le Chesnay France Details
Centre hospitalier Lyon Sud Lyon France Details
Centre Hospitalier Universitaire Nantes Nantes France Details
Nice Hospital, Archet Hospital 1 Clinical Hematology Service Nice France Details
Hopital Saint Louis Paris France Details
Hôpital Haut Leveque, Centre Francois Magendie Pessac France Details
Centre Hospitalier Universitaire Nancy Vandoeuvre les nancy 54511 France Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field